|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product sales | |||||
| Contract research and development | |||||
| Total contract research and development | |||||
| Total revenue, net | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Expenses | |||||
| Research and development | |||||
| Selling, general, and administrative | |||||
| Credit loss expense | |||||
| Total expenses | |||||
| Income from operations | |||||
| Interest income | |||||
| Other income | |||||
| Income before taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Net income per share - basic | |||||
| Net income per share - diluted | |||||
| Weighted Average Number of Shares Outstanding, Basic | |||||
| Weighted Average Number of Shares Outstanding, Diluted | |||||
Loading...